ArticleJournal of gastrointestinal oncology2026
Real-world efficacy and safety of fruquintinib plus PD-1 inhibitors with or without radiotherapy in refractory metastatic colorectal cancer: a single-center retrospective cohort study.
An Yi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.